Home » Healthcare » Pharmaceuticals » Non-Alcoholic Steatohepatitis Market

Non-Alcoholic Steatohepatitis Market By Drug Type (Obeticholic Acid, Aramchol, Saroglitazar, Elafibranor) – Growth, Future Prospects, And Competitive Analysis, 2017 -2025

Price: $4699

Published: | Report ID: 14321 | Report Format : PDF

Market Insights

Nonalcoholic Steatohepatitis (NASH) is the progressive form of Nonalcoholic Fatty Liver Disease (NAFLD), wherein excessive fat deposition causes inflammation and damage to the liver, eventually leading to cirrhosis and increasing risk of liver failure and hepatocellular carcinoma in some cases.

The report titled “Global Nonalcoholic Steatohepatitis Market- Growth, Future Prospects and Competitive Analysis, 2017–2025” offers strategic insights into the Nonalcoholic Steatohepatitis market along with the market size and estimates for the duration 2017 to 2025. The research study covers in-depth analysis of market segments based on drug type, and different geographical region.

In order to help strategic decision makers, the report also includes competitive profiling of the leading players in global Nonalcoholic Steatohepatitis market, attractive investment proposition and market positioning of key manufacturers sections.

Geographically, the global Nonalcoholic Steatohepatitis market is studied for the following regional markets:

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East and Africa
    • GCC
    • Rest of MEA

Market size and forecast for these regional and country level markets are presented in this study for the period 2015-2025. Market growth rates for the forecast period 2017-2025 are also included in this report, considering 2016 as the base year.

Along with quantitative information, qualitative information sets and assessment tools are provided in this study for better analysis of the overall market scenario and future prospects. Information such as pipeline analysis, market inclination insights and drivers, challenges and opportunities assists the readers for understanding the ongoing trends in the global Nonalcoholic Steatohepatitis market. Tools such as market positioning of key players and attractive investment proposition provide the readers with insights on the competitive scenario of the global Nonalcoholic Steatohepatitis market. This report concludes with company profiles section that highlights major information about the key players engaged in global Nonalcoholic Steatohepatitis market. In-depth competitive environment analysis and historical years (2015) market size data are also provided in the report.

Thus, the research study provides a holistic view of the global Nonalcoholic Steatohepatitis market, offering market size and estimates for the period from 2017 to 2025, keeping in mind the above-mentioned factors.

Chapter 1 Preface
1.1 Report Description
1.1.1 Purpose of the Report
1.1.2 Target Audience
1.1.3 USP and Key Offerings
1.2 Research Scope
1.3 Research Methodology
1.3.1 Phase I – Secondary Research
1.3.2 Phase II – Primary Research
1.3.3 Phase III – Expert Panel Review
1.3.4 Assumptions

Chapter 2 Executive Summary
2.1 Non-Alcoholic Steatohepatitis Market Portraiture
2.2 Non-Alcoholic Steatohepatitis Market, by Drug Type, 2016 (US$ Mn)
2.3 Non-Alcoholic Steatohepatitis Market, by Geography, 2016 (Value %)

Chapter 3 Global Non-Alcoholic Steatohepatitis Market Analysis
3.1 Global Non-Alcoholic Steatohepatitis Market Overview
3.2 Market Dynamics
3.2.1 Market Drivers
3.2.1.1 Lucrative Pipeline for NASH Therapeutics
3.2.1.2 Alarming rise in the diabetic and Obese Population Globally
3.2.2 Challenges
3.2.2.1 High Prices of the drug considering the long duration of the treatment
3.2.2.2 Minimum Diagnostic Techniques for NASH
3.2.3 Opportunities
3.2.3.1 NASH Biomarker Development
3.3 Attractive Investment Proposition
3.4 Competitive Analysis: Global Non-Alcoholic Steatohepatitis Market, 2016 (Value %)

Chapter 4 Global Non-Alcoholic Steatohepatitis Market Analysis, By Drug Type
4.1 Overview
4.1.1 Market Attractive Proposition of Non-Alcoholic Steatohepatitis Market, by Drug Type, 2016
4.2 Obeticholic Acid
4.3 Aramchol
4.4 Saroglitazar
4.5 Elafibranor

Chapter 5 Global Non-Alcoholic Steatohepatitis Market, By Geography
5.1 Preface
5.2 North America (U.S. & Canada)
5.2.1 North America Non-Alcoholic Steatohepatitis Market, by Drug Type, 20152025 (US$ Mn)
5.3 Europe (U.K., Germany & Rest of Europe)
5.3.1 Europe Non-Alcoholic Steatohepatitis Market, by Drug Type, 2015-2025 (US$ Mn)
5.4 Asia-Pacific (China, Japan & Rest of Asia-Pacific)
5.4.1 Asia Pacific Non-Alcoholic Steatohepatitis Market, by Drug Type, 20152025 (US$ Mn)
5.5 Latin America (Brazil, Mexico and Rest of LATAM)
5.5.1 Latin America Non-Alcoholic Steatohepatitis Market, by Drug Type, 20152025 (US$ Mn)
5.6 Middle East and Africa (GCC and Rest of MEA)
5.6.1 Middle East and Africa Non-Alcoholic Steatohepatitis Market, by Drug Type, 2015-2025 (US$ Mn)

Chapter 6 Company Profiles
6.1 AstraZeneca plc
6.2 Intercept Pharmaceutical Inc.
6.3 Galmed Pharmaceuticals
6.4 GENFIT SA
6.5 Allergan
6.6 Gilead Science Inc.
6.7 Zydus Cadila
6.8 Immuron Ltd.
6.9 Conatus Pharmaceuticals
6.10 Novo Nordisk
6.11 Enzo Biochem, Inc.
6.12 Raptor Pharmaceuticals

List of Figures

FIG. 1 Non-Alcoholic Steatohepatitis Market: Research Methodology
FIG. 2 Non-Alcoholic Steatohepatitis Market, by Drug Type, 2016 (US$ Mn)
FIG. 3 Non-Alcoholic Steatohepatitis Market, by Geography, 2016 (Value %)
FIG. 4 Attractive Investment Proposition
FIG. 5 Competitive Analysis: Global Alpha Mannosidosis Market, 2016 (Value %)
FIG. 6 Global Obeticholic Acid Market(US$ Mn), 2015-2025
FIG. 7 Global Aramchol Market(US$ Mn), 2015-2025
FIG. 8 Global Saroglitazar Market (US$ Mn), 2015-2025
FIG. 9 Global Elafibranor Market (US$ Mn), 2015-2025

List of Tables

TABLE 1 Global Non-Alcoholic Steatohepatitis Market, By Drug Type (US$ Mn), 2015– 2025
(Value)
TABLE 2 Global Non-Alcoholic Steatohepatitis Market, by Geography, 2015 – 2025 (US$ Mn)
TABLE 3 North America Non-Alcoholic Steatohepatitis Market, by Drug Type, 2015 – 2025 (US$ Mn)
TABLE 4 North America Non-Alcoholic Steatohepatitis Market, by Country, 2015 – 2025 (US$ Mn)
TABLE 5 Europe Non-Alcoholic Steatohepatitis Market, by Drug Type, 2015 – 2025 (US$ Mn)
TABLE 6 Europe Non-Alcoholic Steatohepatitis Market, by Country, 2015 – 2025 (US$ Mn)
TABLE 7 Asia Pacific Non-Alcoholic Steatohepatitis Market, by Drug Type, 2015 – 2025 (US$ Mn)
TABLE 8 Asia – Pacific Non-Alcoholic Steatohepatitis Market, by Country, 2015 – 2025 (US$ Mn)
TABLE 9 Latin Non-Alcoholic Steatohepatitis Market, by Drug Type, 2015 – 2025 (US$ Mn)
TABLE 10 Latin America Non-Alcoholic Steatohepatitis Market, by Country, 2015 – 2025 (US$ Mn)
TABLE 11 Middle East and Africa Non-Alcoholic Steatohepatitis Market, by Drug Type, 2015 – 2025
(US$ Mn)
TABLE 12 Middle East and Africa Non-Alcoholic Steatohepatitis Market, by Country, 2015 – 2025
(US$ Mn)
TABLE 13 AstraZeneca plc: Company Snapshot (Business Description; Financial Performance;
Product Position/Portfolio; News Coverage)
TABLE 14 Intercept Pharmaceutical Inc.: Company Snapshot (Business Description; Financial
Performance; Product Position/Portfolio; News Coverage)
TABLE 15 Galmed Pharmaceuticals: Company Snapshot (Business Description; Financial
Performance; Product Position/Portfolio; News Coverage)
TABLE 16 GENFIT SA: Company Snapshot (Business Description; Financial Performance; Product
Position/Portfolio; News Coverage)
TABLE 17 Allergan: Company Snapshot (Business Description; Financial Performance; Product
Position/Portfolio; News Coverage)
TABLE 18 Gilead Science Inc.: Company Snapshot (Business Description; Financial Performance;
Product Position/Portfolio; News Coverage)
TABLE 19 Zydus Cadila: Company Snapshot (Business Description; Financial Performance; Product
Position/Portfolio; News Coverage)
TABLE 20 Immuron Ltd.: Company Snapshot (Business Description; Financial Performance; Product
Position/Portfolio; News Coverage)
TABLE 21 Conatus Pharmaceuticals: Company Snapshot (Business Description; Financial
Performance; Product Position/Portfolio; News Coverage)
TABLE 22 Novo Nordisk: Company Snapshot (Business Description; Financial Performance; Product
Position/Portfolio; News Coverage)
TABLE 23 Enzo Biochem, Inc.: Company Snapshot (Business Description; Financial Performance;
Product Position/Portfolio; News Coverage)
TABLE 24 Raptor Pharmaceuticals: Company Snapshot (Business Description; Financial
Performance; Product Position/Portfolio; News Coverage)

Frequently Asked Questions:

What is the size of Non-Alcoholic Steatohepatitis Market?

The market for Non-Alcoholic Steatohepatitis Market is expected to reach US$ XX Bn by 2025.

What is the Non-Alcoholic Steatohepatitis Market CAGR?

The Non-Alcoholic Steatohepatitis Market is expected to see significant CAGR growth over the coming years, at XX%.

What is the Forecast period considered for Non-Alcoholic Steatohepatitis Market?

The report is forecasted from 2017-2025.

What is the base year considered for Non-Alcoholic Steatohepatitis Market?

The base year of this report is 2016.

Non-Alcoholic Malt Beverages Market

Published:
Report ID: 69473

Non-Alcoholic Steatohepatitis Clinical Trials Market

Published:
Report ID: 63706

Non-Alcoholic Concentrated Syrup Market

Published:
Report ID: 14334

Non-Alcoholic Energy Drinks Market

Published:
Report ID: 14315

Non-Alcoholic Steatohepatitis (Nash) Biomarkers Market

Published:
Report ID: 19212

Fermented Foods And Beverages Market

Published:
Report ID: 73381

Kegs Market

Published:
Report ID: 7729

Japan Flavored Syrup Market

Published:
Report ID: 48957

Digestion Resistant Maltodextrin Market

Published:
Report ID: 43655

Periodontal Disease Market

Published:
Report ID: 64532

Cocaine Intoxication Treatment Market

Published:
Report ID: 3673

Cloud-Based Drug Discovery Platform Market

Published:
Report ID: 74389

Intranasal Corticosteroids Market

Published:
Report ID: 74344

Artificial Urinary Sphincter Market

Published:
Report ID: 69140

Canine Dilated Cardiomyopathy Drugs Market

Published:
Report ID: 73871

Saudi Arabia Pharmaceutical Market

Published:
Report ID: 72720

Prinzmetal Angina Therapeutics Market

Published:
Report ID: 72626

UK Pharmaceutical Contract Sales Organizations Market

Published:
Report ID: 72562

U.S. Pharmaceutical Contract Sales Organizations Market

Published:
Report ID: 72550

Purchase Options

The report comes as a view-only PDF document, optimized for individual clients. This version is recommended for personal digital use and does not allow printing.
$4699

To meet the needs of modern corporate teams, our report comes in two formats: a printable PDF and a data-rich Excel sheet. This package is optimized for internal analysis and multi-location access, making it an excellent choice for organizations with distributed workforce.
$5699

The report will be delivered in printable PDF format along with the report’s data Excel sheet. This license offers 100 Free Analyst hours where the client can utilize Credence Research Inc.’s research team. It is highly recommended for organizations seeking to execute short, customized research projects related to the scope of the purchased report.
$7699

Smallform of Sample request

Have a question?

User Profile

Don’t settle for less – trust Mitul to help you find the best solution.

Report delivery within 24 to 48 hours

– Other Info –

What people say?-

User Review

I am very impressed with the information in this report. The author clearly did their research when they came up with this product and it has already given me a lot of ideas.

Jana Schmidt
CEDAR CX Technologies

– Connect with us –

Phone

+91 6232 49 3207


support

24/7 Research Support


sales@credenceresearch.com

– Research Methodology –

Going beyond the basics: advanced techniques in research methodology

– Trusted By –

Pepshi, LG, Nestle
Motorola, Honeywell, Johnson and johnson
LG Chem, SIEMENS, Pfizer
Unilever, Samsonite, QIAGEN